Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · IEX Real-Time Price · USD
10.41
-0.65 (-5.88%)
May 16, 2022 4:00 PM EDT - Market closed

Total Valuation

JANX has a market cap or net worth of $433.36 million. The enterprise value is $71.50 million.

Market Cap433.36M
Enterprise Value71.50M

Important Dates

The next earnings date is Friday, June 17, 2022, before market open.

Estimated Earnings DateJun 17, 2022
Ex-Dividend Daten/a

Share Statistics

JANX has 41.63 million shares outstanding. The number of shares has increased by 3,618.17% in one year.

Shares Outstanding41.63M
Shares Change (YoY)+3,618.17%
Shares Change (QoQ)+75.58%
Owned by Insiders (%)11.01%
Owned by Institutions (%)96.76%
Float11.77M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio89.43
PB Ratio1.22
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales14.75
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 29.14, with a Debt / Equity ratio of 0.00.

Current Ratio29.14
Quick Ratio28.93
Debt / Equity0.00
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -11.80%, which is considered low. The company has a ROIC of -15.80%.

Return on Equity (ROE)-11.80%
Return on Assets (ROA)-11.40%
Return on Capital (ROIC)-15.80%
Revenue Per Employee$146,848
Profits Per Employee-$1.33M
Employee Count33
Asset Turnover0.01
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-38.76%
50-Day Moving Average12.75
200-Day Moving Average16.88
Average Volume (30 Days)77,875

Short Selling Information

The latest short interest is 2.82 million, so 6.78% of the outstanding shares have been sold short.

Short Interest2.82M
Short % of Shares Out6.78%
Short % of Float24.00%
Short Ratio (days to cover)48.29

Income Statement

In the last 12 months, JANX had revenue of $4.85 million and -43.80 million in losses. Earnings per share was -$1.39.

Revenue4.85M
Gross Profit4.85M
Operating Income-44.19M
Net Income-43.80M
EBITDA-43.61M
EBIT-43.80M
Earnings Per Share (EPS)-$1.39
Full Income Statement

Balance Sheet

The company has $362.02 million in cash and $153,000 in debt, giving a net cash position of $361.86 million or $8.69 per share.

Cash & Cash Equivalents362.02M
Total Debt153,000
Net Cash361.86M
Net Cash Per Share$8.69
Book Value356.08M
Book Value Per Share8.55
Working Capital352.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.06 million and capital expenditures -$2.30 million, giving a free cash flow of -$36.36 million.

Operating Cash Flow-34.06M
Capital Expenditures-2.30M
Free Cash Flow-36.36M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -911.82% and -903.80%.

Gross Margin100.00%
Operating Margin-911.82%
Pretax Marginn/a
Profit Margin-903.80%
EBITDA Margin-899.98%
EBIT Margin-903.80%
FCF Margin-750.33%

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-10.11%
FCF Yield-8.39%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-3,618.17%
Shareholder Yield-3,618.17%
Dividend Details

Analyst Forecast

The average price target for JANX is $31.96, which is 207.01% higher than the current price. The consensus rating is "Buy".

Price Target$31.96
Price Target Difference207.01%
Analyst ConsensusBuy
Analyst Count10
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a